Equity Profile

CVS

CVS Health Corporation

Health CareHealth Care Services$121.5B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

CVS Health Corporation operates in the health care sector, providing a range of services including pharmacy benefits, retail pharmacy, and health care services. As a major player in health care services, CVS is positioned to benefit from trends such as increasing consumer health awareness and the growing demand for integrated health solutions.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of profitability and will indicate how well CVS is managing its costs and revenues.

$1.85

Revenue

Revenue growth reflects the company's ability to attract and retain customers, which is vital for sustaining long-term growth.

$100.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

CVS Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+17.38%

Avg Stock Reaction

+4.06%

Last Quarter Recap

In Q1 2026, CVS reported an EPS of $2.57, significantly beating expectations of $2.21, which resulted in a 7.65% increase in stock price the following day. The strong performance continues a trend of exceeding earnings expectations.

Management Promises & Guidance

Focus on expanding digital health services.
Commitment to improving customer experience in retail locations.
Plans to enhance pharmacy benefit management offerings.

Expectations

Wall Street Expectations

Analysts are generally optimistic about CVS's upcoming earnings, expecting solid EPS and revenue figures based on historical performance. The company's ability to maintain its growth trajectory will be closely scrutinized.

Bull Case

If CVS can exceed the EPS estimate and show strong revenue growth, it may indicate robust demand for its services and lead to a positive stock reaction.

Bear Case

Conversely, if CVS falls short of earnings expectations or provides weak guidance, it could raise concerns about its growth prospects and negatively impact the stock.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.85

EPS is a critical measure of profitability and will indicate how well CVS is managing its costs and revenues.

Revenue

$100.1B

Revenue growth reflects the company's ability to attract and retain customers, which is vital for sustaining long-term growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will CVS achieve an EPS of at least $1.85?

This number is crucial for maintaining investor confidence and could significantly impact stock performance.

How does CVS plan to drive revenue growth beyond the expected $100.1B?

Understanding the company's strategy for growth will help investors gauge its long-term sustainability.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate CVS's ability to leverage its integrated health services to drive revenue growth, especially in a competitive landscape.

Supporting Evidence

CVS has consistently beaten EPS estimates, indicating strong operational execution.

The company's focus on digital health solutions could provide a competitive edge that isn't fully reflected in current estimates.

Key Risk

If CVS's revenue growth falls below $100.1B, it could challenge the optimistic outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing CVS's ability to maintain strong earnings against potential headwinds in the health care sector.

Bull Confirmed If

Exceeding EPS of $1.85 with revenue growth above $100.1B would confirm the bull case.

Bear Confirmed If

Falling short of the $1.85 EPS target would indicate potential challenges in profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±7.03%

Historical Avg

±5.4%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±7.0% while CVS has averaged ±5.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

35.7%

Calls (563K)P/C Ratio: 0.42Puts (383K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If CVS beats expectations, history suggests a potential stock increase of around 4.06%, confirming strong operational performance.

In-Line / Cautious

An in-line report may lead to muted reactions as investors await further guidance, reflecting uncertainty.

Miss

A miss could result in a significant drop, with historical patterns indicating a potential decline in stock price.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on digital health service adoption rates.
2Any commentary on customer retention strategies.
3Insights into pharmacy benefit management performance.
4Details on cost management initiatives.
5Future growth strategies in retail pharmacy.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

PreviewView

Jul27

ARLPBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of profitability and will indicate how well CVS is managing its costs and revenues.

$1.85

Revenue

Revenue growth reflects the company's ability to attract and retain customers, which is vital for sustaining long-term growth.

$100.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

CVS Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+17.38%

Avg Stock Reaction

+4.06%

Last Quarter Recap

Management Promises & Guidance

Focus on expanding digital health services.
Commitment to improving customer experience in retail locations.
Plans to enhance pharmacy benefit management offerings.

Expectations

Wall Street Expectations

Bull Case

If CVS can exceed the EPS estimate and show strong revenue growth, it may indicate robust demand for its services and lead to a positive stock reaction.

Bear Case

Conversely, if CVS falls short of earnings expectations or provides weak guidance, it could raise concerns about its growth prospects and negatively impact the stock.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.85

EPS is a critical measure of profitability and will indicate how well CVS is managing its costs and revenues.

Revenue

$100.1B

Revenue growth reflects the company's ability to attract and retain customers, which is vital for sustaining long-term growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will CVS achieve an EPS of at least $1.85?

This number is crucial for maintaining investor confidence and could significantly impact stock performance.

How does CVS plan to drive revenue growth beyond the expected $100.1B?

Understanding the company's strategy for growth will help investors gauge its long-term sustainability.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate CVS's ability to leverage its integrated health services to drive revenue growth, especially in a competitive landscape.

Supporting Evidence

CVS has consistently beaten EPS estimates, indicating strong operational execution.

The company's focus on digital health solutions could provide a competitive edge that isn't fully reflected in current estimates.

Key Risk

If CVS's revenue growth falls below $100.1B, it could challenge the optimistic outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing CVS's ability to maintain strong earnings against potential headwinds in the health care sector.

Bull Confirmed If

Exceeding EPS of $1.85 with revenue growth above $100.1B would confirm the bull case.

Bear Confirmed If

Falling short of the $1.85 EPS target would indicate potential challenges in profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±7.03%

Historical Avg

±5.4%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±7.0% while CVS has averaged ±5.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

35.7%

Calls (563K)P/C Ratio: 0.42Puts (383K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If CVS beats expectations, history suggests a potential stock increase of around 4.06%, confirming strong operational performance.

In-Line / Cautious

An in-line report may lead to muted reactions as investors await further guidance, reflecting uncertainty.

Miss

A miss could result in a significant drop, with historical patterns indicating a potential decline in stock price.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on digital health service adoption rates.
2Any commentary on customer retention strategies.
3Insights into pharmacy benefit management performance.
4Details on cost management initiatives.
5Future growth strategies in retail pharmacy.